UK markets close in 7 hours 15 minutes

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
30.75-0.75 (-2.38%)
At close: 04:00PM EDT
30.70 -0.05 (-0.16%)
After hours: 07:22PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.78B
Enterprise value 1.56B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.70
Price/book (mrq)3.01
Enterprise value/revenue 5.94
Enterprise value/EBITDA -9.04

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 3148.38%
S&P500 52-week change 322.64%
52-week high 343.21
52-week low 311.46
50-day moving average 335.00
200-day moving average 327.52

Share statistics

Avg vol (3-month) 3895.13k
Avg vol (10-day) 3957.51k
Shares outstanding 557.82M
Implied shares outstanding 657.82M
Float 856.94M
% held by insiders 11.78%
% held by institutions 1112.63%
Shares short (15 Apr 2024) 412.25M
Short ratio (15 Apr 2024) 417
Short % of float (15 Apr 2024) 427.79%
Short % of shares outstanding (15 Apr 2024) 421.19%
Shares short (prior month 15 Mar 2024) 412.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -78.44%
Operating margin (ttm)-65.70%

Management effectiveness

Return on assets (ttm)-15.87%
Return on equity (ttm)-30.80%

Income statement

Revenue (ttm)262.36M
Revenue per share (ttm)4.59
Quarterly revenue growth (yoy)31.80%
Gross profit (ttm)N/A
EBITDA -176.4M
Net income avi to common (ttm)-205.8M
Diluted EPS (ttm)-3.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)311.14M
Total cash per share (mrq)5.38
Total debt (mrq)91.88M
Total debt/equity (mrq)15.57%
Current ratio (mrq)5.98
Book value per share (mrq)10.21

Cash flow statement

Operating cash flow (ttm)-111.38M
Levered free cash flow (ttm)-67.14M